Recommended Products
Acute Care Pressure Ulcer News

United Hebrew of New Rochelle Ranked in Top 4% of Best Performers in Nursing Home Care; Awarded $146,000 for Superior Performance

(Vocus) June 18, 2010 -- United Hebrew of New Rochelle has been ranked in the top 4 percent of http://www.unitedhebrewgeriatric.org/skalet_nursing_home.asp [nursing home facilities] by New York State...

Read more...


Global Advanced Wound Care Products to Exceed $12.3 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

San Jose, CA (PRWEB) February 18, 2010 -- Advanced wound care includes products that employ new technologies to reduce healing, and the time involved in treating chronic and acute wounds. Advanced...

Read more...


New International Guidelines on Pressure Ulcer Prevention and Treatment Now Available

Washington, D.C. (PRWEB) November 8, 2009 -- The National Pressure Ulcer Advisory Panel (NPUAP) and the European Pressure Ulcer Advisory Panel (EPUAP) announced the availability for purchase of the...

Read more...


National Pressure Ulcer Advisory Panel Releases White Paper on Nutrition

Washington, D.C. (PRWEB) May 30, 2009 -- One to three million people develop pressure ulcers (commonly known as bed sores) in the U.S. each year. Pressure ulcers reduce overall quality of life by...

Read more...


Wound Be Gone®: Quickly Gaining Strong Support from Clinician Experts in the Field of Wound Healing

Bellwood, IL (PRWEB) March 12, 2009 -- Wound Be Gone® is a novel product based on revolutionary technology in the healing of wounds. Based on a unique and patented principle, it is vastly...

Read more...


Wound-Be-Gone™: New Product Set Standard of Care for Non-Healing Sores

Bellwood, IL (PRWEB) January 5, 2009 - Wound-Be-Gone™ (http://www.woundbegone.com/)], lead product offering from Wake Pharm US, is now available and is changing the way people treat chronic,...

Read more...


Pre and Post-Operative Use of CaldolorĀ® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly ...

NASHVILLE, Tenn., Aug. 30 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of new data supporting the safety and efficacy of CaldolorĀ® (ibuprofen) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen ...

Read more...